A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Clinical trial NCT03802695 · RECRUITING

Trial details

NCT number: NCT03802695
Sponsor: Orca Biosystems, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Mixed Phenotype Acute Leukemia Acute Lymphoblastic Leukemia

Start date: 2019-04-08
Primary completion: 2027-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.